R35320 Search Results


rbt  (Millipore)
90
Millipore rbt
Rbt, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rbt/product/Millipore
Average 90 stars, based on 1 article reviews
rbt - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
turbo dnaase i  (Thermo Fisher)
90
Thermo Fisher turbo dnaase i
Turbo Dnaase I, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/turbo dnaase i/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
turbo dnaase i - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
polyol r3530  (Perstorp Chemicals GmbH)
90
Perstorp Chemicals GmbH polyol r3530
Polyol R3530, supplied by Perstorp Chemicals GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyol r3530/product/Perstorp Chemicals GmbH
Average 90 stars, based on 1 article reviews
polyol r3530 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
rifabutin  (Millipore)
90
Millipore rifabutin
Distribution of <t>rifabutin</t> and rifampin MICs. MICs for both rifampin and rifabutin were determined using either standard MHII culture conditions or modified RPMI plus serum culture conditions for A. baumannii , S. aureus , E. coli , K. pneumoniae , and P. aeruginosa . The numbers of clinical isolates tested are given in the symbol keys. Statistical comparisons were made by Mann-Whitney test comparing MICs obtained in RPMI and MHII.
Rifabutin, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rifabutin/product/Millipore
Average 90 stars, based on 1 article reviews
rifabutin - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
epcam antibody  (NSJ Bioreagents)
N/A
Additional name(s) for this target protein: Epithelial cell adhesion molecule, TROP1
   Buy from Supplier
bcl2a1a antibody  (NSJ Bioreagents)
N/A
Additional name(s) for this target protein: Bcl-2-related protein A1
   Buy from Supplier
anti human igg f ab 2 secondary antibody  (Abcepta)
N/A
   Buy from Supplier
rbp4 antibody  (NSJ Bioreagents)
N/A
Additional name(s) for this target protein: Retinol binding protein 4
   Buy from Supplier
precursor mirna expression clone for mouse mmu-mir-1962  (Genecopoeia)
N/A
Hairpin precursor miRNA of approximately 150 nucleotides is cloned into lentiviral or non-viral vectors for delivery in virtually all cell types.
   Buy from Supplier
vipr1 antibody  (NSJ Bioreagents)
N/A
Additional name(s) for this target protein: Vasoactive intestinal peptide receptor 1
   Buy from Supplier
chimaerin 2 antibody  (NSJ Bioreagents)
N/A
Additional name(s) for this target protein: CHN2, Chimerin
   Buy from Supplier

Image Search Results


Distribution of rifabutin and rifampin MICs. MICs for both rifampin and rifabutin were determined using either standard MHII culture conditions or modified RPMI plus serum culture conditions for A. baumannii , S. aureus , E. coli , K. pneumoniae , and P. aeruginosa . The numbers of clinical isolates tested are given in the symbol keys. Statistical comparisons were made by Mann-Whitney test comparing MICs obtained in RPMI and MHII.

Journal: mSphere

Article Title: In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae

doi: 10.1128/msphere.00920-21

Figure Lengend Snippet: Distribution of rifabutin and rifampin MICs. MICs for both rifampin and rifabutin were determined using either standard MHII culture conditions or modified RPMI plus serum culture conditions for A. baumannii , S. aureus , E. coli , K. pneumoniae , and P. aeruginosa . The numbers of clinical isolates tested are given in the symbol keys. Statistical comparisons were made by Mann-Whitney test comparing MICs obtained in RPMI and MHII.

Article Snippet: Briefly, bacteria were serially passaged 20 times with sub-MICs of rifabutin (R3530-25MG; Sigma) or rifampin (R3501-1G; Sigma) in MHII (90000-602; VWR) or RPMI (11875119; Gibco) media at 37°C and 200 rpm.

Techniques: Modification, MANN-WHITNEY

In vivo rifampin and rifabutin efficacy. Larvae were challenged with various bacterial inocula to determine each strain’s LD 100 . No-infection controls received PBS. To determine treatment efficacy, larvae were challenged with 1.1E6 CFU/larva A. baumannii HUMC1, 7.6E6 CFU/larva E. coli JJ1886, 5.5E2 CFU/larva P. aeruginosa PAO1, 3.4E7 CFU/larva K. pneumoniae KPC-KP1, or 2.2E7, 3.3E7, or 2.0E7 CFU/larva S. aureus LAC before being treated with PBS, RFB, or RIF. No-infection controls received 2 doses of PBS. Statistical comparisons, which are not significant unless indicated, were made by a log rank (Mantel-Cox) test comparing survival between dose-equivalent drug-treated groups.

Journal: mSphere

Article Title: In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae

doi: 10.1128/msphere.00920-21

Figure Lengend Snippet: In vivo rifampin and rifabutin efficacy. Larvae were challenged with various bacterial inocula to determine each strain’s LD 100 . No-infection controls received PBS. To determine treatment efficacy, larvae were challenged with 1.1E6 CFU/larva A. baumannii HUMC1, 7.6E6 CFU/larva E. coli JJ1886, 5.5E2 CFU/larva P. aeruginosa PAO1, 3.4E7 CFU/larva K. pneumoniae KPC-KP1, or 2.2E7, 3.3E7, or 2.0E7 CFU/larva S. aureus LAC before being treated with PBS, RFB, or RIF. No-infection controls received 2 doses of PBS. Statistical comparisons, which are not significant unless indicated, were made by a log rank (Mantel-Cox) test comparing survival between dose-equivalent drug-treated groups.

Article Snippet: Briefly, bacteria were serially passaged 20 times with sub-MICs of rifabutin (R3530-25MG; Sigma) or rifampin (R3501-1G; Sigma) in MHII (90000-602; VWR) or RPMI (11875119; Gibco) media at 37°C and 200 rpm.

Techniques: In Vivo, Infection

20-day serial passage mutant selection. For HUMC1, the starting MIC for both drugs was 3.13 mg/L in MHII. In RPMI, however, the starting MICs for rifampin and rifabutin were 3.13 mg/L and <0.05 mg/L, respectively. For ABNIH1, the starting MIC for both drugs was 3.13 mg/L in both MHII and RPMI. Despite HUMC1 initially being more susceptible to rifabutin in RPMI, it was still possible to select high-level resistance mutants. Similarly, no difference in rifabutin resistance emergence was observed between the hypersusceptible strain HUMC1 and the susceptible strain ABNIH1 after serial passage.

Journal: mSphere

Article Title: In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae

doi: 10.1128/msphere.00920-21

Figure Lengend Snippet: 20-day serial passage mutant selection. For HUMC1, the starting MIC for both drugs was 3.13 mg/L in MHII. In RPMI, however, the starting MICs for rifampin and rifabutin were 3.13 mg/L and <0.05 mg/L, respectively. For ABNIH1, the starting MIC for both drugs was 3.13 mg/L in both MHII and RPMI. Despite HUMC1 initially being more susceptible to rifabutin in RPMI, it was still possible to select high-level resistance mutants. Similarly, no difference in rifabutin resistance emergence was observed between the hypersusceptible strain HUMC1 and the susceptible strain ABNIH1 after serial passage.

Article Snippet: Briefly, bacteria were serially passaged 20 times with sub-MICs of rifabutin (R3530-25MG; Sigma) or rifampin (R3501-1G; Sigma) in MHII (90000-602; VWR) or RPMI (11875119; Gibco) media at 37°C and 200 rpm.

Techniques: Mutagenesis, Selection